To provide for a limitation on availability of funds for Executive Office of the President, Office of National Drug Control Policy, Other Federal Drug Control Programs for fiscal year 2024.

HR 2073 sets a spending limit of $118,327,000 for federal drug control programs in fiscal year 2024, including the Office of National Drug Control Policy and related initiatives. This bill directly affects funding for national drug control efforts by restricting available resources to this specific cap. The key provision is a statutory limit that overrides other funding authorizations for these programs during FY2024. It does not change drug policy or create new programs, but restricts the total funding available for existing federal drug control activities.